{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:46:17Z","timestamp":1788399977028,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["BOF16\/GOA\/017"],"award-info":[{"award-number":["BOF16\/GOA\/017"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002913","name":"Vlaamse Overheid","doi-asserted-by":"publisher","award":["B\/14730\/01"],"award-info":[{"award-number":["B\/14730\/01"]}],"id":[{"id":"10.13039\/501100002913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002913","name":"Vlaamse Overheid","doi-asserted-by":"publisher","award":["G0F4617N"],"award-info":[{"award-number":["G0F4617N"]}],"id":[{"id":"10.13039\/501100002913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00406-020-01142-x","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T08:04:36Z","timestamp":1590739476000},"page":"211-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is twice daily LF-rTMS a viable treatment option for treatment-resistant OCD? Results from an open-label feasibility study"],"prefix":"10.1007","volume":"271","author":[{"given":"Hannelore L. N.","family":"Tandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"De Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Audenaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-3041","authenticated-orcid":false,"given":"Chris","family":"Baeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert M. D.","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0193-953X(05)70176-3","volume":"23","author":"E Horwath","year":"2000","unstructured":"Horwath E, Weissman M (2000) The epidemiology and cross-national presentation of obsessive-compulsive disorder. Psychiatr Clin North Am 23:493\u2013550. https:\/\/doi.org\/10.1016\/S0193-953X(05)70176-3","journal-title":"Psychiatr Clin North Am"},{"key":"1142_CR2","doi-asserted-by":"crossref","unstructured":"Fineberg N A, Brown A, & Pampaloni I (2012). Evidence-based pharmacotherapy of obsessive\u2013compulsive disorder. In: Essential evidence-based psychopharmacology, 2nd edn. Cambridge University Press, pp 128\u2013170","DOI":"10.1017\/CBO9780511910395.009"},{"key":"1142_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-014-0317-5","volume":"14","author":"D Veale","year":"2014","unstructured":"Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J (2014) Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry 14:1\u201313. https:\/\/doi.org\/10.1186\/s12888-014-0317-5","journal-title":"BMC Psychiatry"},{"key":"1142_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pnpbp.2015.12.004","volume":"70","author":"M Atmaca","year":"2016","unstructured":"Atmaca M (2016) Treatment-refractory obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 70:127\u2013133. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.12.004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1142_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/npp.2015.292","volume":"41","author":"K Dunlop","year":"2016","unstructured":"Dunlop K, Woodside B, Olmsted M, Colton P, Giacobbe P, Downar J (2016) Reductions in cortico-striatal hyperconnectivity accompany successful treatment of obsessive-compulsive disorder with dorsomedial prefrontal rTMS. Neuropsychopharmacology 41:1395\u20131403. https:\/\/doi.org\/10.1038\/npp.2015.292","journal-title":"Neuropsychopharmacology"},{"key":"1142_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/da.22363","volume":"32","author":"M Modirrousta","year":"2015","unstructured":"Modirrousta M, Shams E, Katz C, Mansouri B, Moussavi Z, Sareen J, Enns M (2015) The efficacy of deep repetitive transcranial magnetic stimulation over the medial prefrontal cortex in obsessive compulsive disorder: results from an open-label study. Depression and Anxiety. 32:445\u2013450. https:\/\/doi.org\/10.1002\/da.22363","journal-title":"Depression and Anxiety."},{"key":"1142_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jpsychires.2013.03.022","volume":"47","author":"MT Berlim","year":"2013","unstructured":"Berlim MT, Neufeld NH, Van den Eynde F (2013) Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): An exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res 47:999\u20131006. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.03.022","journal-title":"J Psychiatr Res"},{"key":"1142_CR8","unstructured":"National Institute for Health and Care Excellence (NICE) (2020). Interventional procedure consultation document: transcranial magnetic stimulation for obsessive-compulsive disorder, draft recommendations. NICE 2020"},{"key":"1142_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2007.06.026","volume":"55","author":"M Hallet","year":"2007","unstructured":"Hallet M (2007) Transcranial magnetic stimulation: a primer. Neuron 55:187\u2013199","journal-title":"Neuron"},{"key":"1142_CR10","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0006-3223(00)01065-9","volume":"4","author":"AM Speer","year":"2000","unstructured":"Speer AM, Kimbrell TA, Wasserman EM et al (2000) Opposite effects of high and low frequency rTMS on region brain activity in depressed patients. Biol Psychiatry 4:1133\u20131141","journal-title":"Biol Psychiatry"},{"key":"1142_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1017\/S0033291713002237","volume":"44","author":"M Morgi\u00e8ve","year":"2014","unstructured":"Morgi\u00e8ve M, N'Diaye K, Haynes W et al (2014) Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging. Psychol Med 44:1461\u20131473","journal-title":"Psychol Med"},{"key":"1142_CR12","first-page":"405","volume":"33","author":"JY Rotge","year":"2008","unstructured":"Rotge JY, Guehl D, Dilharreguy B et al (2008) Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci 33:405\u2013412","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"1142_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","volume":"132","author":"C Pittenger","year":"2011","unstructured":"Pittenger C, Bloch MH, Williams K (2011) Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 132(3):314\u2013332","journal-title":"Pharmacol Ther"},{"key":"1142_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","volume":"32","author":"L Menzies","year":"2008","unstructured":"Menzies L, Chamberlain S, Laird A, Thelen S, Sahakian BJ, Bullmore E (2008) Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisisted. Neurosci Biobehav Rev 32:525\u2013549","journal-title":"Neurosci Biobehav Rev"},{"key":"1142_CR15","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3389\/fpsyg.2018.02017","volume":"9","author":"C Baeken","year":"2018","unstructured":"Baeken C (2018) Accelerated rTMS: a potential treatment to alleviate refractory depression. Fron Psychol 9:2017. https:\/\/doi.org\/10.3389\/fpsyg.2018.02017","journal-title":"Fron Psychol"},{"key":"1142_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jad.2016.04.015","volume":"200","author":"R Duprat","year":"2016","unstructured":"Duprat R, Desmyter S, Rudi DR, Van Heeringen K, Van Den Abbeele D, Tandt H et al (2016) Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission? J Affect Disord 200:6\u201314. https:\/\/doi.org\/10.1016\/j.jad.2016.04.015","journal-title":"J Affect Disord"},{"issue":"Suppl 20","key":"1142_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0924-9338(99)80239-9","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998) The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59(Suppl 20):22\u201333. https:\/\/doi.org\/10.1016\/S0924-9338(99)80239-9","journal-title":"J Clin Psychiatry."},{"key":"1142_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al (1989) The yale-brown obsessive compulsive scale: I. Development, use, and reliability. Archives General Psychiatry. 46:1006\u20131011. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007","journal-title":"Archives General Psychiatry."},{"key":"1142_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1017\/S0033291700035558","volume":"26","author":"AJ Rush","year":"1996","unstructured":"Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996) The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med 26:477\u2013486. https:\/\/doi.org\/10.1017\/S0033291700035558","journal-title":"Psychol Med"},{"key":"1142_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"key":"1142_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/wps.20299","volume":"15","author":"D Mataix-Cols","year":"2016","unstructured":"Mataix-Cols D, Fern\u00e1ndez de la Cruz L, Nordsletten AE, Lenhard F, Isomura K, Simpson HB (2016) Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder. World Psychiatry 15:80\u201381. https:\/\/doi.org\/10.1002\/wps.20299","journal-title":"World Psychiatry"},{"key":"1142_CR22","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.clinph.2009.08.016","volume":"120","author":"S Rossi","year":"2009","unstructured":"Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Avanzini G, Bestmann S et al (2009) Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 120:2008\u20132039. https:\/\/doi.org\/10.1016\/j.clinph.2009.08.016","journal-title":"Clin Neurophysiol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01142-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-020-01142-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01142-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:54:18Z","timestamp":1622246058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-020-01142-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s00406-020-01142-x","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"22 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors declare any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}